Associations of genetic polymorphisms of SAA1 with cerebral infarction

Lipids Health Dis. 2013 Aug 29:12:130. doi: 10.1186/1476-511X-12-130.

Abstract

Background: Serum amyloid A protein (SAA) is both an inflammatory factor and an apolipoprotein. However, the relation between genetic polymorphisms of SAA and cerebral infarction (CI) remains unclear.

Methods and results: The previously reported 4 Single Nucleotide Polymorphisms (rs12218, rs4638289, rs7131332, and rs11603089) of SAA1 gene were genotyped by TaqMan method in a case-control study including 287 cerebral infarction patients and 376 control subjects. We found rs12218 CC genotype and rs7131332 AA genotype were more frequent among CI patients than among controls (9.76% versus 3.19%, P = 0.001; 32.75% versus 24.20%; p = 0.017; respectively). After adjustment of confounding factors such as sex, age, smoking, drinking, hypertension, diabetes, and lipids profile, the difference remained significant in rs12218 (P < 0.01, OR = 2.106, 95% CI: 1.811-7.121).

Conclusion: Genetic polymorphism of SAA1 may be a genetic maker of cerebral infarction in Chinese.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alleles
  • Asian People
  • Case-Control Studies
  • Cerebral Infarction / ethnology
  • Cerebral Infarction / genetics*
  • Female
  • Gene Expression
  • Gene Frequency
  • Genetic Markers
  • Genetic Predisposition to Disease*
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Serum Amyloid A Protein / genetics*

Substances

  • Genetic Markers
  • SAA1 protein, human
  • Serum Amyloid A Protein